ADP blockers ( clopidogrel , prasugrel , ticagrelor , ticlopidine ( treatment of atherosclerosis



 ADP blockers ( clopidogrel , prasugrel , ticagrelor , ticlopidine ( treatment of atherosclerosis

Mechanism of Action: 

  • When a wound occurs as a result of increased fat or as a result of increased blood sugar or blood pressure, fibrinogen comes by linking the platelets together, forming a chain and gradually multiplying until it blocks the blood vessel and causes a clot.
  • The role of clopidogrel comes when it binds to its receptors (P2T12), works to inhibit fibrinogen, so it does not clump and leads to an increase in blood fluidity .

Pharmacological action : 

Ticagrelor has the advantage of having less duration of action as it binds specifically reversibly, unlike the others .

Uses in general : 

They provide blood fluidity and prevent clots in any of the arteries or veins. 

 ticlopidine uses : 

  •  particular in the treatment when the heart muscle dies .
  •  to that it is used in the event that the patient does not benefit from aspirin and clots form .
  •  storke . 

Side effects: 

  • an imbalance in liver enzymes. 
  •  Digestive problems. 
  •  Steven's Johnson syndrome. 
  •  Deficiency of blood components causing anemia. 
  • bleeding.
  • Dizziness.

clopidogrel, prasugrel, ticagrelor uses: 

  • used in pre-infarction angina intermediate syndrome. 
  •  Treats non-ST-segment elevation myocardial infarction.  
  • percotenous coronary intervention PCI, which are stents with plates attached to each other, forming chains and clots.

side effects:

  •  clopidogrel: bleeding. Steven Johnson syndrome. Decrease in the number of plates.
  • prasugrel: edema. Hypertension.  bleeding.
  • ticlopidine: bleeding. dyspnea. Elevation in serum creatinine (kidney function).

Precaution :

These medicines should be stopped at least two days before any surgery .

Comments



Font Size
+
16
-
lines height
+
2
-